Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

August 17, 2019

Correspondence response
Welcome to EULAR’s guidelines for the use of big data techniques in rheumatic and musculoskeletal diseases. Response to: ‘On using machine learning algorithms to define clinically meaningful patient subgroups’ by Knevel and Huizinga
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-215989
Correspondence
Risk of gout flares after vaccination
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-216146

August 16, 2019

Correspondence
Steroid sparing effect: an essential element in assessing therapeutic efficacy in SLE: response to ‘Time to change the primary outcome of lupus trials’ by Houssiau
Free

Shereen Oon, Molla Huq, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-216113
Correspondence
Ultrasonographic damages of major salivary glands are associated with cryoglobulinemic vasculitis and lymphoma in primary Sjogren’s syndrome: are the ultrasonographic features of the salivary glands new prognostic markers in Sjogren's syndrome?
Free

Guillaume Coiffier, Amélie Martel, Jean-David Albert, Alain Lescoat, Aurore Bleuzen, Aleth Perdriger, Michel De Bandt, François Maillot

doi: 10.1136/annrheumdis-2019-216122
Correspondence response
Fostering the application of the MS score in systemic juvenile idiopathic arthritis. Response to: ‘MS score in systemic juvenile idiopathic arthritis: suitable for routine use?’ by Chi et al
Free

Francesca Minoia, Angelo Ravelli

doi: 10.1136/annrheumdis-2019-216067

August 13, 2019

Correspondence
How to communicate in science
Free

Lars Klareskog, Anca Irinel Catrina, Camilla Svensson, Vivianne Malmstrom

doi: 10.1136/annrheumdis-2019-216016
Correspondence response
Response to: “How to communicate in science” by Klareskog et al
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-216045

August 12, 2019

Correspondence response
Response to: ‘Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis’ by Lai et al
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-215992

August 07, 2019

Correspondence response
Response to: ‘Performance of the systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population’, by Rodríguez-González et al
Free

Diogo Jesus, Ana Matos, Carla Henriques, Margherita Zen, Andrea Doria, Luís Sousa Inês

doi: 10.1136/annrheumdis-2019-216110
Correspondence response
Response to: ‘Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?’ by Coiffier et al
Free

Marion Couderc, Jean-Jacques Dubost

doi: 10.1136/annrheumdis-2019-215991

August 03, 2019

Correspondence
Standardisation of myositis-specific antibodies: where are we today?
Free

Michael Mahler, Jean-Baptiste Vulsteke, Xavier Bossuyt, Ellen De Langhe, Minoru Satoh

doi: 10.1136/annrheumdis-2019-216003
Correspondence
Anti-Ku syndrome with elevated CK: association with myocardial involvement in systemic sclerosis
Free

Corrado Campochiaro, Giacomo De Luca, Maria De Santis

doi: 10.1136/annrheumdis-2019-216070

August 02, 2019

Correspondence
MS score in systemic juvenile idiopathic arthritis: suitable for routine use?
Free

Huihui Chi, Zhihong Wang, Chengde Yang, Yutong Su

doi: 10.1136/annrheumdis-2019-216041

July 31, 2019

Correspondence response
Response to: ‘Response to: ‘Alcohol is not the missing link between Porphyromonas gingivalis related periodontitis and radiologic progression in early Rheumatoid arthritis’ by Hillion et al’ by Marotte and Paul
Free

Alexandre Bellier, Xavier Romand, Athan Baillet

doi: 10.1136/annrheumdis-2019-215962

July 30, 2019

Correspondence response
Response to: ‘Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations’ by Orsolini et al
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215944
Correspondence
Augmented versus artificial intelligence for stratification of patients with myositis
Free

Michael Mahler, Brenden Rossin, Olga Kubassova

doi: 10.1136/annrheumdis-2019-216000
Correspondence response
Artificial intelligence should always be guided by human intelligence. Response to ‘Augmented vs. artificial intelligence for stratification of patients with myositis’ by Mahler et al
Free

Alain Meyer, Lionel Spielmann, François Séverac

doi: 10.1136/annrheumdis-2019-216014

July 29, 2019

Correspondence
Performance of the Systemic lupus erythematosus disease activity score (SLE-DAS) in a Latin American population.
Free

Melissa G Rodríguez-González, Grissell A Valero-Gaona, Tania Vargas-Aguirre, Luis M Amezcua Guerra

doi: 10.1136/annrheumdis-2019-216028

July 22, 2019

Correspondence response
Treat to target in PsA should focus on clinical measures. Response to: ‘DAPSA versus cDAPSA: do we need use CRP?’ by Gonçalves et al
Free

Leonieke J J van Mens, Marleen G H van de Sande, Arno W R van Kuijk, Dominique Baeten, Laura C Coates

doi: 10.1136/annrheumdis-2019-215990
Correspondence
DAPSA versus cDAPSA: Do we need to use CRP?
Free

Rafaela Silva Guimarães Gonçalves, Lays Miranda de Almeida Martins, Henrique de Ataide Mariz, Andrea Tavares Dantas, Angela Luzia Branco Pinto Duarte

doi: 10.1136/annrheumdis-2019-215960

July 12, 2019

Correspondence
Association between proton pump inhibitors therapy and fracture risk in patients with rheumatoid arthritis
Free

Shih-Wei Lai, Yu-Hung Kuo, Kuan-Fu Liao

doi: 10.1136/annrheumdis-2019-215982
Correspondence
Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?
Free

Guillaume Coiffier, Sandrine Jousse-Joulin, Divi Cornec, Ronan Garlantézec, Aurore Bleuzen, Elisabeth Diot, Patrick Jego, Alice Ballerie, Alain Lescoat

doi: 10.1136/annrheumdis-2019-215972

July 11, 2019

Correspondence response
Response to: ‘Treatment of systemic lupus erythematosus: don’t forget hydroxychloroquine’ by Michaud et al
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215817
Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Rachel Knevel, Tom WJ Huizinga

doi: 10.1136/annrheumdis-2019-215959

July 08, 2019

Correspondence response
Mortality has improved in RA, but we must remain vigilant. Response to: ‘Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA’ by Matthijssen et al
Free

Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers

doi: 10.1136/annrheumdis-2019-215863
Correspondence response
Response to: ‘Achieving lupus low disease activity and remission states under belimumab in refractory systemic lupuserythematosus: time and organ involvement matter’ by Sbeih et al
Free

Mandana Nikpour, Molla Huq, Shereen Oon

doi: 10.1136/annrheumdis-2019-215922
Correspondence
Achieving lupus low-disease activity and remission states under belimumab in refractory systemic lupus erythematosus: time and organ involvement matter
Free

Nabiha Sbeih, Alexis Mathian, Marc Pineton de Chambrun, Raphael Lhote, Noël Zahr, Micheline Pha, Fleur Cohen-Aubart, Julien Haroche, Miguel Hié, Sophie Jouffroy, Neila Benameur, Hervé Devilliers, Zahir Amoura

doi: 10.1136/annrheumdis-2019-215732
Correspondence response
Response to: ‘Association of proton pump inhibitors with fracture risk in patients with rheumatoid arthritis’ by Sugiyama
Free

Gulsen Ozen, Kaleb Michaud

doi: 10.1136/annrheumdis-2019-215775

July 05, 2019

Correspondence response
Response to: ‘Less antibiotics but no inferior effect for bacterial arthritis’ by Zhang et al
Free

Ilker Uçkay, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215909
Correspondence
Is it currently reasonable to offer short, 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?
Free

Guillaume Coiffier, Marion Couderc, Raphaele Seror, Geraldine Bart, Christelle Darrieutort-Laffite, Benoit Le Goff

doi: 10.1136/annrheumdis-2019-215887
Correspondence response
Response to: ‘Is it currently reasonable to offer short 14-day antibiotic therapies after a surgical synovectomy in native joint septic arthritis?’ by Coiffier et al
Free

Ilker Uçkay, Amanda Gonzalez, Ergys Gjika

doi: 10.1136/annrheumdis-2019-215905
Correspondence
Less antibiotics but no inferior effect for bacterial arthritis
Free

Jian Tian, Chao Cheng, Fangjie Zhang

doi: 10.1136/annrheumdis-2019-215682

July 04, 2019

Correspondence response
Effects of maternal medication on long-term outcome in congenital heart block remain to be established. Response to: ‘Comorbidity and long-term outcome in patients with congenital heart block and their siblings exposed to Ro/SSA autoantibodies in utero’ by Satis et al
Free

Johannes Mofors, Sven-Erik Sonesson, Marie Wahren-Herlenius

doi: 10.1136/annrheumdis-2019-215677
Correspondence response
Response to: ‘Impact of Janus kinase inhibitors on the risk of cardiovascular events in patients with rheumatoid arthritis: systematic review and meta-analysis of randomised controlled trials’ by Lee and Song
Free

Wenhui Xie, Shiyu Xiao, Zhuoli Zhang

doi: 10.1136/annrheumdis-2019-215841
Correspondence response
Response to: ‘Can biomarkers differentiate psoriatic arthritis from osteoarthritis?’ by Tian et al
Free

Vinod Chandran, Richard J Cook, Dafna D Gladman

doi: 10.1136/annrheumdis-2019-215762
Correspondence response
Response to: ‘Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndrome’ by van den Hoogen et al
Free

Mariana J Kaplan, Kerry A Casey

doi: 10.1136/annrheumdis-2019-215811

July 03, 2019

Correspondence response
Response to: ‘Concerns about the operational definition of remission in 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus’ by Rua-Figueroa and Erausquin
Free

Antonis Fanouriakis, George Bertsias, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2019-215810
Correspondence
Bone health, an often forgotten comorbidity in systemic lupus erythematosus: a comment on the new recommendations
Free

Giovanni Orsolini, Irene Elizabeth Maria Bultink, Giovanni Adami, Angelo Fassio, Ombretta Viapiana, Alessandro Giollo, Davide Gatti, Maurizio Rossini

doi: 10.1136/annrheumdis-2019-215896
Correspondence response
Response to: ‘Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand’’ by Holmdahl
Free

René Toes, David S Pisetsky

doi: 10.1136/annrheumdis-2019-215870

June 27, 2019

Correspondence response
Response to: ‘Can IL-1 be used as a target for osteoarthritis?’ by Cheng et al
Free

Margreet Kloppenburg, Marc Levesque

doi: 10.1136/annrheumdis-2019-215612

June 22, 2019

Correspondence
Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA
Free

Xanthe ME Matthijssen, Tom WJ Huizinga, Ellis Niemantsverdriet, Annette HM van der Helm-van Mil

doi: 10.1136/annrheumdis-2019-215843

June 21, 2019

Correspondence
On using machine learning algorithms to define clinically meaningful patient subgroups
Free

Iago Pinal-Fernandez, Andrew Lee Mammen

doi: 10.1136/annrheumdis-2019-215852
Correspondence
Comment on editorial ‘Pathogenic effector functions of ACPA: where do we stand?’
Free

Rikard Holmdahl

doi: 10.1136/annrheumdis-2019-215857

June 19, 2019

Correspondence response
Response to: ‘Mycophenolate mofetil: a step forward in the induction treatment of ANCA-associated vasculitis? Comment on the article by Jones et al’ by Vandergheynst et al
Free

Rachel B Jones, Thomas F Hiemstra, Michael Walsh, David Jayne, Lorraine Harper

doi: 10.1136/annrheumdis-2019-215658

June 18, 2019

Correspondence
Association between ankylosing spondylitis and venous thromboembolism
Free

Shih-Wei Lai

doi: 10.1136/annrheumdis-2019-215854

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

August 17, 2019

August 16, 2019

August 13, 2019

August 12, 2019

August 07, 2019

August 03, 2019

August 02, 2019

July 31, 2019

July 30, 2019

July 29, 2019

July 22, 2019

July 20, 2019

July 15, 2019

July 13, 2019

July 12, 2019

July 11, 2019

July 08, 2019

July 05, 2019

July 04, 2019

July 03, 2019

June 27, 2019

June 22, 2019

June 21, 2019

June 19, 2019

June 18, 2019

Pages